Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HOLM R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 79 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rotterud, R; Berner, A; Holm, R; Skovlund, E; Fossa, SD
      p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder

      BJU INTERNATIONAL
    2. Holm, R; Mullertz, A; Christensen, E; Hoy, CE; Kristensen, HG
      Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    3. Holm, R; Mullertz, A; Pedersen, GP; Kristensen, HG
      Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids

      PHARMACEUTICAL RESEARCH
    4. Holm, R; Skovlund, E; Skomedal, H; Florenes, VA; Tanum, G
      Reduced expression of p21(WAF1) is an indicator of malignant behaviour in anal carcinomas

      HISTOPATHOLOGY
    5. Florenes, VA; Maelandsmo, GM; Faye, R; Nesland, JM; Holm, R
      Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

      JOURNAL OF PATHOLOGY
    6. Florenes, VA; Faye, RS; Maelandsmo, GM; Nesland, JM; Holm, R
      Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma

      CLINICAL CANCER RESEARCH
    7. Holm, R
      A highly sensitive nonisotopic detection method for in situ hybridization

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    8. De Jonge, ETM; Lindeque, BG; Burger, W; Nesland, JM; Holm, R
      Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    9. Janco, M; Sykora, D; Svec, F; Frechet, JMJ; Schweer, J; Holm, R
      Rapid determination of molecular parameters of synthetic polymers by precipitation/redissolution high-performance liquid chromatography using "molded" monolithic column

      JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
    10. Baekelandt, M; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    11. Baekelandt, MM; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer

      ANTICANCER RESEARCH
    12. Helland, A; Kraggerud, SM; Kristensen, GB; Holm, R; Abeler, VM; Huebner, K; Borresen-Dale, AL; Lothe, RA
      Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 inrelation to survival

      INTERNATIONAL JOURNAL OF CANCER
    13. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study

      CLINICAL CANCER RESEARCH
    14. de Jonge, ETM; Viljoen, E; Lindeque, BG; Amant, F; Nesland, JM; Holm, R
      The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    15. Skomedal, H; Helland, A; Kristensen, GB; Holm, R; Borresen-Dale, AL
      Allelic imbalance at chromosome region 11q23 in cervical carcinomas

      EUROPEAN JOURNAL OF CANCER
    16. Reed, W; Florenes, VA; Holm, R; Hannisdal, E; Nesland, JM
      Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    17. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

      ANNALS OF ONCOLOGY
    18. Baekelandt, M; Kristensen, GB; Nesland, JM; Trope, CG; Holm, R
      Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    19. Hennig, EM; Di Lonardo, A; Venuti, A; Holm, R; Marcante, ML; Nesland, JM
      HPV 16 in multiple neoplastic lesions in women with CINIII

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    20. Hennig, EM; Kvinnsland, S; Holm, R; Nesland, JM
      Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas

      ACTA ONCOLOGICA
    21. Hennig, EM; Suo, ZH; Karlsen, F; Holm, R; Thoresen, S; Nesland, JM
      HPV positive bronchopulmonary carcinomas in women with previous high-gradecervical intraepithelial neoplasia (CIN III)

      ACTA ONCOLOGICA
    22. Lie, AK; Skarsvag, S; Skomedal, H; Haugen, OA; Holm, R
      Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    23. Baekelandt, M; Kristensen, GB; Trope, CG; Nesland, JM; Holm, R
      Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer

      ANTICANCER RESEARCH
    24. Hennig, EM; Suo, ZH; Thoresen, S; Holm, R; Kvinnsland, S; Nesland, JM
      Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).

      BREAST CANCER RESEARCH AND TREATMENT
    25. Skomedal, H; Kristensen, GB; Lie, AK; Holm, R
      Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21,p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas

      GYNECOLOGIC ONCOLOGY
    26. Skomedal, H; Kristensen, GB; Nesland, JM; Borresen-Dale, AL; Trope, C; Holm, R
      TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, MDM2, and EGFR in cancers of the uterine corpus

      JOURNAL OF PATHOLOGY
    27. OHLCKERS P; HOLM R; JAKOBSEN H; KVISTEROY T; KITTILSLAND G; LARSEN A; NESE M; NILSEN SM; FERBER A
      AN INTEGRATED RESONANT ACCELEROMETER MICROSYSTEM FOR AUTOMOTIVE APPLICATIONS

      Sensors and actuators. A, Physical
    28. KALANTARI M; KARLSEN F; KRISTENSEN G; HOLM R; HAGMAR B; JOHANSSON B
      DISRUPTION OF THE E1 AND E2 READING FRAMES OF HPV-16 IN CERVICAL-CARCINOMA IS ASSOCIATED WITH POOR-PROGNOSIS

      International journal of gynecological pathology
    29. SMITHSORENSEN B; KAERN J; HOLM R; DORUM A; TROPE C; BORRESENDALE AL
      THERAPY EFFECT OF EITHER PACLITAXEL OR CYCLOPHOSPHAMIDE COMBINATION TREATMENT IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER AND RELATION TO TP53 GENE STATUS

      British Journal of Cancer
    30. HELLAND A; KARLSEN F; DUE EU; HOLM R; KRISTENSEN G; BORRESENDALE AL
      MUTATIONS IN THE TP53 GENE AND PROTEIN EXPRESSION OF P53, MDM-2 AND P21 WAF-1 IN PRIMARY CERVICAL CARCINOMAS WITH NO OR LOW HUMAN-PAPILLOMAVIRUS LOAD/

      British Journal of Cancer
    31. SORLIE T; MARTELPLANCHE G; HAINAUT P; LEWALTER J; HOLM R; BORRESENDALE AL; MONTESANO R
      ANALYSIS OF P53, P16(MTS1), P21(WAF1) AND H-RAS IN ARCHIVED BLADDER-TUMORS FROM WORKERS EXPOSED TO AROMATIC-AMINES

      British Journal of Cancer
    32. FLORENES VA; MAELANDSMO GM; KERBEL RS; SLINGERLAND JM; NESLAND JM; HOLM R
      PROTEIN EXPRESSION OF THE CELL-CYCLE INHIBITOR P27(KIP1) IN MALIGNANT-MELANOMA - INVERSE CORRELATION WITH DISEASE-FREE SURVIVAL

      The American journal of pathology
    33. HOLM R; CHARSLEY P
      A STUDY OF INDENTATION IN AN AL-CU-MG ALLOY

      Materials science & engineering. A, Structural materials: properties, microstructure and processing
    34. BERNER A; FRANZEN S; HOLM R
      HPV-16 INFECTION IN A PATIENT WITH 2 PRIMARY SQUAMOUS-CELL CARCINOMAS- OF THE UTERINE CERVIX AND THE ANAL MUCOSA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    35. ZHANG ZY; SUE ZH; SUDBO J; HOLM R; BOYSEN M; REITH A
      DIAGNOSTIC IMPLICATIONS OF P53 PROTEIN REACTIVITY IN NASAL-MUCOSA OF NICKEL WORKERS

      Analytical and quantitative cytology and histology
    36. KRAGGERUD SM; JACOBSEN KD; BERNER A; STOKKE T; HOLM R; SMEDSHAMMER L; BORRESENDALE AL; FOSSA SD
      A COMPARISON OF DIFFERENT MODES FOR THE DETECTION OF P53 PROTEIN ACCUMULATION - A STUDY OF BLADDER-CANCER

      Pathology research and practice
    37. LOPES JM; BRULAND OS; BJERKEHAGEN B; SILVA MC; HOLM R; PETTERSEN EO; SOLHEIM OP; SOBRINHOSIMOES M; NESLAND JM
      SYNOVIAL SARCOMA - IMMUNOHISTOCHEMICAL EXPRESSION OF P-GLYCOPROTEIN AND GLUTATHIONE-S-TRANSFERASE-PI AND CLINICAL DRUG-RESISTANCE

      Pathology research and practice
    38. HOLM R; FLORENES VA; ERIKSTEIN B; NESLAND JM
      EXPRESSION OF STROMELYSIN-3 IN MEDULLARY CARCINOMA OF THE BREAST

      Anticancer research
    39. KAREEM BN; KARLSEN F; HOLM R; HENNIG EM; SUO ZH; EMILSEN E; HELLESYLT E; NESLAND JM
      A NOVEL GRID POLYMERASE CHAIN-REACTION (G-PCR) APPROACH AT ULTRASTRUCTURAL LEVEL TO DETECT TARGET DNA IN CELL-CULTURES AND TISSUES

      Journal of pathology
    40. SKOMEDAL H; KRISTENSEN GB; ABELER VM; BORRESENDALE AL; TROPE C; HOLM R
      TP53 PROTEIN ACCUMULATION AND GENE MUTATION IN RELATION TO OVEREXPRESSION OF MDM2 PROTEIN IN OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS

      Journal of pathology
    41. CHITEMERERE M; ANDERSEN TI; HOLM R; KARLSEN F; BORRESEN AL; NESLAND JM
      TP53 ALTERATIONS IN ATYPICAL DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA IN-SITU OF THE BREAST

      Breast cancer research and treatment
    42. KARLSEN F; KALANTARI M; JENKINS A; PETTERSEN E; KRISTENSEN G; HOLM R; JOHANSSON B; HAGMAR B
      USE OF MULTIPLE PCR PRIMER SETS FOR OPTIMAL DETECTION OF HUMAN PAPILLOMAVIRUS

      Journal of clinical microbiology
    43. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF NM23 NDP KINASE PROTEIN EXPRESSION IN CERVICAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY/

      Gynecologic oncology
    44. TANUM G; HOLM R
      ANAL CARCINOMA - A CLINICAL APPROACH TO P53 AND RB GENE PROTEINS

      Oncology
    45. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY

      Cancer
    46. MAELANDSMO GM; FLORENES VA; HOVIG E; OYJORD T; ENGEBRAATEN O; HOLM R; BORRESEN AL; FODSTAD O
      INVOLVEMENT OF THE PRH P16/CDK4/CYCLIN D1 PATHWAY IN THE TUMORIGENESIS OF SPORADIC MALIGNANT MELANOMAS/

      British Journal of Cancer
    47. MAELANDSMO GM; HOLM R; FODSTAD O; KERBEL RS; FLORENES VA
      CYCLIN KINASE INHIBITOR P21(WAF1 CLP1) IN MALIGNANT-MELANOMA - REDUCED EXPRESSION IN METASTATIC LESIONS/

      The American journal of pathology
    48. LIE ES; KARLSEN F; HOLM R
      PRESENCE OF HUMAN PAPILLOMAVIRUS IN SQUAMOUS-CELL LARYNGEAL CARCINOMAS - A STUDY OF 39 CASES USING POLYMERASE CHAIN-REACTION AND IN-SITU HYBRIDIZATION

      Acta oto-laryngologica
    49. FLORENES VA; HOLM R; FODSTAD O
      ACCUMULATION OF P53 PROTEIN IN HUMAN-MALIGNANT MELANOMA - RELATIONSHIPS TO CLINICAL OUTCOME

      Melanoma research
    50. KARLSEN F; KRISTENSEN G; HOLM R; CHITEMERERE M; BERNER A; HAGMAR BM
      HIGH-INCIDENCE OF HUMAN PAPILLOMAVIRUS IN 146 CERVICAL CARCINOMAS - ASTUDY USING 3 DIFFERENT PAIRS OF CONSENSUS PRIMERS, AND DETECTING VIRAL GENOMES WITH PUTATIVE DELETIONS

      European journal of cancer
    51. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF NM23, CATHEPSIN-D, EGFR AND C-ERBB-2 IN CERVICAL-CANCER

      European journal of cancer
    52. HOLM R; HOIE J; KAALHUS O; NESLAND JM
      IMMUNOHISTOCHEMICAL DETECTION OF NM23 NDP KINASE AND CATHEPSIN-D IN MEDULLARY CARCINOMAS OF THE THYROID-GLAND/

      Virchows Archiv
    53. HOLM R
      NULL-CELL ADENOMAS AND ONCOCYTOMAS OF THE PITUITARY-GLAND

      Pathology research and practice
    54. BERNTORP E; BRACKMANN HH; DECHAVANNE M; GAZENGEL C; JOHNSSON H; LAURIAN Y; TENGBORN L; STAHL C; HOLM R
      PROPHYLACTIC TREATMENT WITH A B-DOMAIN-DELETED RECOMBINANT FACTOR-VIII (R-VII SQ) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA-A

      Thrombosis and haemostasis
    55. BERNTORP E; JOHNSSON H; TENGBORN L; VANDRAAT KF; PETERS M; TENCATE JW; SAVIDGE G; STAHL C; HOLM R
      DELETION OF THE B-DOMAIN IN A RECOMBINANT FACTOR-VIII (R-VIII SQ) DOES NOT AFFECT THE MAIN KINETIC-PROPERTIES - 3 PHARMACOKINETIC STUDIES IN 36 PATIENTS WITH SEVERE HEMOPHILIA-A

      Thrombosis and haemostasis
    56. SUO ZH; SU W; HOLM R; NESLAND JM
      LACK OF EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN HUMAN ESOPHAGEAL SQUAMOUS-CELL CARCINOMAS

      Anticancer research
    57. LOPES JM; BJERKEHAGEN B; HOLM R; BRULAND O; SOBRINHOSIMOES M; NESLAND JM
      PROLIFERATIVE ACTIVITY OF SYNOVIAL SARCOMA - AN IMMUNOHISTOCHEMICAL EVALUATION OF KI-67 LABELING INDEXES OF 52 PRIMARY AND RECURRENT TUMORS

      Ultrastructural pathology
    58. SKOMEDAL H; KRISTENSEN G; HOLM R
      EXPRESSION OF RETINOBLASTOMA TUMOR-SUPPRESSOR GENE PROTEIN, EPIDERMALGROWTH-FACTOR RECEPTOR, AND C-ERBB-2 ONCOPROTEIN IN PRIMARY VAGINAL CARCINOMAS

      Gynecologic oncology
    59. SKOMEDAL H; KRISTENSEN G; HELLAND A; NESLAND JM; KOOI S; BORRESEN AL; HOLM R
      TP53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN PRIMARY VAGINAL CARCINOMAS

      British Journal of Cancer
    60. MAKAR AP; HOLM R; KRISTENSEN GB; NESLAND JM; TROPE CG
      THE EXPRESSION OF C-ERBB-2 (HER-2 NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES/

      International journal of gynecological cancer
    61. HOLM R; TANUM G; KARLSEN F; NESLAND JM
      PREVALENCE AND PHYSICAL STATE OF HUMAN PAPILLOMAVIRUS DNA IN ANAL CARCINOMAS

      Modern pathology
    62. LOPES JM; BJERKEHAGEN B; HOLM R; BRULAND O; SOBRINHOSIMOES M; NESLAND JM
      IMMUNOHISTOCHEMICAL PROFILE OF SYNOVIAL SARCOMA WITH EMPHASIS ON THE EPITHELIAL-TYPE DIFFERENTIATION - A STUDY OF 49 PRIMARY TUMORS, RECURRENCES AND METASTASES

      Pathology research and practice
    63. BJERKEHAGEN B; FOSSA SD; RAABE N; HOLM R; NESLAND JM
      TRANSITIONAL-CELL CARCINOMA OF THE RENAL PELVIS AND ITS EXPRESSION OFP53 PROTEIN, C-ERBB-2 PROTEIN, NEURON-SPECIFIC ENOLASE, PHE-5, CHROMOGRANIN, LAMININ AND COLLAGEN TYPE-IV

      European urology
    64. HOLM R; OVER J; WITTIG M; MINNICH R; BERG D; EICKMANS J; HOLTKAMP D; MEYER K; BENNINGHOVEN A
      CHLORINES EFFECTS ON TRIAZOLE INHIBITOR LAYERS ON COPPER

      Materials performance
    65. HOLM R; NESLAND JM
      RETINOBLASTOMA AND P53 TUMOR-SUPPRESSOR GENE PROTEIN EXPRESSION IN CARCINOMAS OF THE THYROID-GLAND

      Journal of pathology
    66. KRISTIANSEN E; JENKINS A; HOLM R
      COEXISTENCE OF EPISOMAL AND INTEGRATED HPV16 DNA IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX

      Journal of Clinical Pathology
    67. FLORENES VA; HOLM R; MYKLEBOST O; LENDAHL U; FODSTAD O
      EXPRESSION OF THE NEUROECTODERMAL INTERMEDIATE FILAMENT NESTIN IN HUMAN MELANOMAS

      Cancer research
    68. DAVID L; NESLAND JM; HOLM R; SOBRINHOSIMOES M
      EXPRESSION OF LAMININ, COLLAGEN-IV, FIBRONECTIN, AND TYPE-IV COLLAGENASE IN GASTRIC-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY OF 87 PATIENTS

      Cancer
    69. ABELER VM; HOLM R; NESLAND JM; KJORSTAD KE
      SMALL-CELL CARCINOMA OF THE CERVIX - A CLINICOPATHOLOGICAL STUDY OF 26 PATIENTS

      Cancer
    70. FLORENES VA; OYJORD T; HOLM R; SKREDE M; BORRESEN AL; NESLAND JM; FODSTAD O
      TP53 ALLELE LOSS, MUTATIONS AND EXPRESSION IN MALIGNANT-MELANOMA

      British Journal of Cancer
    71. HOLM R
      COEXPRESSION OF INSULIN AND SOMATOSTATIN IN SINGLE SECRETORY GRANULESOF A PANCREATIC ENDOCRINE TUMOR - COMMENTARY

      Pathology research and practice
    72. SUO Z; HOLM R; NESLAND JM
      SQUAMOUS-CELL CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY OF CYTOKERATINS AND INVOLUCRIN IN PRIMARY AND METASTATIC TUMORS

      Histopathology
    73. BERNER A; HOLM R; NAESS A; HJORTDAL O
      P53 PROTEIN EXPRESSION IN SQUAMOCELLULAR CARCINOMAS OF THE LIP

      Anticancer research
    74. GORCZYCA W; HOLM R; NESLAND JM
      LAMININ PRODUCTION AND FIBRONECTIN IMMUNOREACTIVITY IN BREAST CARCINOMAS

      Anticancer research
    75. SUO ZH; QVIST H; SU W; HOLM R; GIERCKSKY KE; NESLAND JM
      UNDIFFERENTIATED CARCINOMA - AN IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY

      Anticancer research
    76. HELLAND A; HOLM R; KRISTENSEN G; KAERN J; KARLSEN F; TROPE C; NESLAND JM; BORRESEN AL
      GENETIC ALTERATIONS OF THE TP53 GENE, P53 PROTEIN EXPRESSION AND HPV INFECTION IN PRIMARY CERVICAL CARCINOMAS

      Journal of pathology
    77. PELTOMAKI P; LOTHE RA; AALTONEN LA; PYLKKANEN L; NYSTROMLAHTI M; SERUCA R; DAVID L; HOLM R; RYBERG D; HAUGEN A; BROGGER A; BORRESEN AL; DELACHAPELLE A
      MICROSATELLITE INSTABILITY IS ASSOCIATED WITH TUMORS THAT CHARACTERIZE THE HEREDITARY NONPOLYPOSIS COLORECTAL-CARCINOMA SYNDROME

      Cancer research
    78. ANDERSEN TI; HOLM R; NESLAND JM; HEIMDAL KR; OTTESTAD L; BORRESEN AL
      PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA

      British Journal of Cancer
    79. HOLTKAMP D; BAYER G; HOLM R
      MICROANALYSIS OF FLAWS IN RUBBER COMPOUNDS

      Kautschuk und Gummi, Kunststoffe


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 12:31:51